New health risks for Europeans in a fast-moving drug market

People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2026: Trends and Developments, released today (1). Based on data from 29 countries (EU-27, Norway and Türkiye), the annual review highlights risks to public health posed by the wide availability and use of an increasingly diverse range of substances, often of high potency or purity. New cannabis products continue to appear, while the variety of opioids and stimulants sold is on the rise.…